XML 31 R13.htm IDEA: XBRL DOCUMENT v2.3.0.15
Equity Level 1 (Notes)
9 Months Ended
Sep. 30, 2011
Equity [Abstract] 
Stockholders' Equity Note Disclosure [Text Block]
EQUITY

During the three months ended September 30, 2011, we repurchased 30,798 of our common shares for $3.4 million. Included in this total were rights to 10,798 shares valued at $1.2 million that were surrendered to us pursuant to the terms of a stock-based compensation plan in consideration of the participants' tax burdens that may result from the issuance of common shares under that plan. During the nine months ended September 30, 2011, we repurchased 604,972 of our common shares for $55.5 million. Included in this total were rights to 40,478 shares valued at $4.1 million that were surrendered to us pursuant to the terms of a stock-based compensation plan in consideration of the participants' tax burdens that may result from the issuance of common shares under that plan. Such common shares, unless canceled, may be reissued for a variety of purposes such as future acquisitions, employee stock awards, exchange of the Exchangeable Notes, or settlement of outstanding warrants.

At the annual meeting of shareholders on May 19, 2011 the shareholders approved the cancellation of 702,106 shares of our common stock currently held as treasury stock at a cost of $40.9 million. These treasury shares were canceled on September 2, 2011, after the expiration of the waiting period required under Dutch law. In accordance with ASC 505-30-30-8, we charge the excess of the cost of the treasury stock over its par value to additional paid-in capital. If additional paid-in-capital is not sufficient for this charge, the remainder is charged directly to retained earnings.

In February, May, and August 2011, we paid a quarterly dividend of $0.25 per share of common stock.  In addition, on October 11, 2011, we declared a quarterly dividend of $0.25 per share of common stock for shareholders of record on October 21, 2011 and payable on November 22, 2011.

In 2006, we sold warrants on our common shares, which had an adjusted exercise price in the third quarter of $61.14 per share, with an initial 20-day settlement period beginning in December 2011 through January 2012.  The warrant agreement called for the net value of these warrants to be settled with Core Laboratories N.V. common shares.  During 2011, the settlement of all of the warrants was accelerated through a series of agreements with the holder of the warrants. The warrants were settled in four substantially equal 20-day tranches during May, June, August and September of 2011. In each of the four tranches, the exercise price was adjusted based on the daily volume weighted average price of our common stock. These agreements also gave us the option of settling in either cash or our common stock. During the three months ended September 30, 2011, we settled 3.4 million warrants at an average exercise price of $59.79 for $153.7 million in cash and 37,959 shares of our treasury stock. During the nine months ended September 30, 2011, we settled 6.6 million warrants at an average exercise price of $59.84 for $219.5 million in cash and 706,395 shares of our treasury stock.
The following table summarizes our changes in equity for the nine months ended September 30, 2011 (in thousands):
 
Common
 
Additional
Paid-In
 
Retained
 
Accumulated
Other
Comprehensive
 
Treasury
 
Non-
Controlling
 
Total
(Unaudited)
Shares
 
Capital
 
Earnings
 
Income (Loss)
 
Stock
 
Interests
 
Equity
December 31, 2010
$
1,397

 
$

 
$
536,991

 
$
(6,207
)
 
$
(242,690
)
 
$
2,849

 
$
292,340

Stock options exercised

 
(1,658
)
 

 

 
1,953

 

 
295

Stock based-awards

 
6,007

 
(744
)
 

 
8,078

 

 
13,341

Tax benefit of stock-based awards issued

 
2,315

 

 

 

 

 
2,315

Repurchase of common shares

 

 

 

 
(55,495
)
 

 
(55,495
)
Dividends paid

 

 
(34,356
)
 

 

 

 
(34,356
)
Cancellation of common shares
(21
)
 

 
(40,894
)
 

 
40,915

 

 

Equity component of short-term debt

 
8,355

 

 

 

 

 
8,355

Exchange of Senior Exchangeable Notes

 
(8,425
)
 
(40,394
)
 

 
46,870

 

 
(1,949
)
Settlement of warrants

 
(6,594
)
 
(256,039
)
 

 
43,182

 

 
(219,451
)
Non-controlling interests contribution

 

 

 

 

 
1,193

 
1,193

Non-controlling interests dividends

 

 

 

 

 
(251
)
 
(251
)
Comprehensive income:
 

 
 

 
 

 
 

 
 

 
 

 
 

Amortization of deferred pension costs, net of tax

 

 

 
228

 

 

 
228

Net income (loss)

 

 
131,608

 

 

 
(123
)
 
131,485

Total comprehensive income
 
 
 
 
 
 
 
 
 
 
 
 
131,713

September 30, 2011
$
1,376

 
$

 
$
296,172

 
$
(5,979
)
 
$
(157,187
)
 
$
3,668

 
$
138,050










Comprehensive Income

The components of comprehensive income consisted of the following (in thousands):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2011
 
2010
 
2011
 
2010
 
(Unaudited)
 
(Unaudited)
Net income
$
45,109

 
$
38,763

 
$
131,485

 
$
105,411

Amortization of deferred pension costs, net of tax
76

 
86

 
228

 
257

Total comprehensive income
$
45,185

 
$
38,849

 
$
131,713

 
$
105,668


Accumulated other comprehensive income (loss) consisted of the following (in thousands):

 
September 30,
2011
 
December 31,
2010
 
(Unaudited)
 
 
Prior service cost
$
(764
)
 
$
(853
)
Transition asset
276

 
324

Unrecognized net actuarial loss
(5,491
)
 
(5,678
)
Total accumulated other comprehensive income (loss)
$
(5,979
)
 
$
(6,207
)